112 related articles for article (PubMed ID: 10673750)
1. Rapid and reliable detection of N-ras mutations in acute lymphoblastic leukemia by melting curve analysis using LightCycler technology.
Nakao M; Janssen JW; Seriu T; Bartram CR
Leukemia; 2000 Feb; 14(2):312-5. PubMed ID: 10673750
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of the N-ras gene in acute lymphoblastic leukemia: a study of 125 Japanese pediatric cases.
Yokota S; Nakao M; Horiike S; Seriu T; Iwai T; Kaneko H; Azuma H; Oka T; Takeda T; Watanabe A; Kikuta A; Asami K; Sekine I; Matsushita T; Tsuhciya T; Mimaya J; Koizumi S; Miyake M; Nishikawa K; Takaue Y; Kawano Y; Iwai A; Ishida Y; Matsumoto K; Fujimoto T
Int J Hematol; 1998 Jun; 67(4):379-87. PubMed ID: 9695411
[TBL] [Abstract][Full Text] [Related]
3. Lack of association between N-ras gene mutations and clinical prognosis in Brazilian children with acute lymphoblastic leukemia.
Clementino NC; Yamamoto M; Viana MB; Figueiredo MS; Kerbauy J; Saad ST; Costa FF
Leuk Lymphoma; 2001 Jul; 42(3):473-9. PubMed ID: 11699412
[TBL] [Abstract][Full Text] [Related]
4. Mutations of the p53 and ras genes in childhood t(1;19)-acute lymphoblastic leukemia.
Kawamura M; Kikuchi A; Kobayashi S; Hanada R; Yamamoto K; Horibe K; Shikano T; Ueda K; Hayashi K; Sekiya T
Blood; 1995 May; 85(9):2546-52. PubMed ID: 7727782
[TBL] [Abstract][Full Text] [Related]
5. Potential of LightCycler technology for quantification of minimal residual disease in childhood acute lymphoblastic leukemia.
Eckert C; Landt O; Taube T; Seeger K; Beyermann B; Proba J; Henze G
Leukemia; 2000 Feb; 14(2):316-23. PubMed ID: 10673751
[TBL] [Abstract][Full Text] [Related]
6. RAS and FMS mutations following cytotoxic therapy for childhood acute lymphoblastic leukaemia.
Taylor C; McGlynn H; Carter G; Baker AH; Warren N; Ridge SA; Owen G; Thompson E; Thompson PW; Jacobs A
Leukemia; 1995 Mar; 9(3):466-70. PubMed ID: 7885045
[TBL] [Abstract][Full Text] [Related]
7. Analysis of RAS oncogene mutations in human lymphoid malignancies.
Neri A; Knowles DM; Greco A; McCormick F; Dalla-Favera R
Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9268-72. PubMed ID: 3057505
[TBL] [Abstract][Full Text] [Related]
8. RAS oncogene mutations and outcome of therapy for childhood acute lymphoblastic leukemia.
Perentesis JP; Bhatia S; Boyle E; Shao Y; Shu XO; Steinbuch M; Sather HN; Gaynon P; Kiffmeyer W; Envall-Fox J; Robison LL
Leukemia; 2004 Apr; 18(4):685-92. PubMed ID: 14990973
[TBL] [Abstract][Full Text] [Related]
9. Parental exposure to medications and hydrocarbons and ras mutations in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Shu XO; Perentesis JP; Wen W; Buckley JD; Boyle E; Ross JA; Robison LL;
Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1230-5. PubMed ID: 15247135
[TBL] [Abstract][Full Text] [Related]
10. [Low incidence of point mutation of N-ras oncogene in human gliomas].
Tsurushima H; Ohno T; Tsuboi K; Yoshii Y; Meguro K; Nose T
No Shinkei Geka; 1995 Jul; 23(7):581-6. PubMed ID: 7637839
[TBL] [Abstract][Full Text] [Related]
11. A one-step DGGE scanning method for detection of mutations in the K-, N-, and H-ras oncogenes: mutations at codons 12, 13 and 61 are rare in B-cell non-Hodgkin's lymphoma.
Nedergaard T; Guldberg P; Ralfkiaer E; Zeuthen J
Int J Cancer; 1997 May; 71(3):364-9. PubMed ID: 9139869
[TBL] [Abstract][Full Text] [Related]
12. A highly sensitive assay for mutant ras genes and its application to the study of presentation and relapse genotypes in acute leukemia.
Jacobson DR; Mills NE
Oncogene; 1994 Feb; 9(2):553-63. PubMed ID: 8290266
[TBL] [Abstract][Full Text] [Related]
13. Recurrent KRAS codon 146 mutations in human colorectal cancer.
Edkins S; O'Meara S; Parker A; Stevens C; Reis M; Jones S; Greenman C; Davies H; Dalgliesh G; Forbes S; Hunter C; Smith R; Stephens P; Goldstraw P; Nicholson A; Chan TL; Velculescu VE; Yuen ST; Leung SY; Stratton MR; Futreal PA
Cancer Biol Ther; 2006 Aug; 5(8):928-32. PubMed ID: 16969076
[TBL] [Abstract][Full Text] [Related]
14. Fluorescent oligonucleotide ligation technology for identification of ras oncogene mutations.
Eggerding FA
Mol Biotechnol; 2000 Mar; 14(3):223-33. PubMed ID: 10890013
[TBL] [Abstract][Full Text] [Related]
15. Mutations and expression of the ras family genes in leukemias.
Gougopoulou DM; Kiaris H; Ergazaki M; Anagnostopoulos NI; Grigoraki V; Spandidos DA
Stem Cells; 1996 Nov; 14(6):725-9. PubMed ID: 8948029
[TBL] [Abstract][Full Text] [Related]
16. Polymerase chain reaction/sequencing analysis of ras mutations in paraffin-embedded tissues as compared with 3T3 transfection and polymerase chain reaction/sequencing of frozen tumor deoxyribonucleic acids.
Goodrow TL; Prahalada SR; Storer RD; Manam SV; Leander KR; Kraynak AR; van Zwieten MJ; Nichols WW; Bradley MO
Lab Invest; 1992 Apr; 66(4):504-11. PubMed ID: 1583889
[TBL] [Abstract][Full Text] [Related]
17. Low frequency of ras oncogene mutations in Philadelphia-positive acute leukemia and report of a novel mutation H61 Leu in a single case.
Urbano-Ispizua A; Gill R; Matutes E; Levi S; Wiedemann LM; Catovsky D; Marshall CJ
Leukemia; 1992 Apr; 6(4):342-6. PubMed ID: 1588796
[TBL] [Abstract][Full Text] [Related]
18. [Oncogenes in human leukemia].
Takaku F
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):617-23. PubMed ID: 2650633
[TBL] [Abstract][Full Text] [Related]
19. H-ras oncogene point mutations in arthritic synovium.
Roivainen A; Jalava J; Pirilä L; Yli-Jama T; Tiusanen H; Toivanen P
Arthritis Rheum; 1997 Sep; 40(9):1636-43. PubMed ID: 9324018
[TBL] [Abstract][Full Text] [Related]
20. Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler technology.
Nakao M; Janssen JW; Flohr T; Bartram CR
Cancer Res; 2000 Jun; 60(12):3281-9. PubMed ID: 10866322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
